How Much Upside is Left in Adma Biologics (ADMA)? Wall Street Analysts Think 52.85%
Portfolio Pulse from
Wall Street analysts suggest a potential upside of 52.9% for Adma Biologics (ADMA) based on average price targets. Positive earnings estimate revisions could support this potential increase.
March 05, 2025 | 4:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Adma Biologics (ADMA) has a potential upside of 52.9% according to Wall Street analysts' average price targets. Positive earnings estimate revisions may support this potential increase.
The article highlights a significant potential upside for ADMA based on analyst price targets, which is a strong indicator for investors. Additionally, positive trends in earnings estimate revisions further support the potential for stock price appreciation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100